4143-57-1Relevant articles and documents
Composition and orientation of the core region of novel HIV-1 entry inhibitors influences metabolic stability
Cocklin, Simon,Karadsheh, Rama,Meuser, Megan E.
, (2020)
Fostemsavir/temsavir is an investigational HIV-1 entry inhibitor currently in late-stage clinical trials. Although it holds promise to be a first-in-class Env-targeted entry inhibitor for the clinic, issues with bioavailability relegate its use to salvage